• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Hashimoto's Thyroiditis Encephalopathy Induced by COVID-19 Infection

tetano

Editor, Senior Moderator
Cureus


. 2022 Aug 26;14(8):e28419.
doi: 10.7759/cureus.28419. eCollection 2022 Aug.
Hashimoto's Thyroiditis Encephalopathy Induced by COVID-19 Infection


Misbahuddin Khaja[SUP] 1 [/SUP], Zaheer A Qureshi[SUP] 2 [/SUP], Kazi Samsuddoha[SUP] 3 [/SUP], Vikram Itare[SUP] 3 [/SUP], Petr Stastka[SUP] 4 [/SUP], Jaydeep Mahasamudram[SUP] 3 [/SUP], Faryal Altaf[SUP] 3 [/SUP], Arundhati Dileep[SUP] 5 [/SUP]



Affiliations
Free PMC article

Abstract

Various factors can lead to thyroiditis, including any acute inflammatory process, especially viral illness. While coronavirus disease 2019 (COVID-19) has been linked to disorders of various systems, there is a lack of literature showing an association of coronavirus with the cause of Hashimoto's thyroiditis. Several possible mechanisms for this outcome have been proposed; chief among them is molecular mimicry. Here, we are reporting a case of Hashimoto's thyroiditis incited by COVID-19 in a 34-year-old obese female who presented with anxiety, behavioral changes, and repeated head movements. The patient had an elevated thyroid stimulating hormone (TSH) level, a low thyroxine (T4) level, and a positive anti-microsomal antibody screen. The patient also tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. Ultrasound of the patient's neck showed an enlarged heterogeneous thyroid gland. Thyroid replacement therapy with intravenous levothyroxine was started with the subsequent oral transition. Concurrently, she received antibiotics, steroids, and low-molecular-weight heparin for COVID-19. The patient exhibited significant improvement in her mental status, with an eventual return to baseline. The results of the thyroid panel obtained at the outpatient follow-up were normal. Although there is a paucity of data to show COVID-19 as a cause of this painless thyroiditis, this case demonstrates such causality between these two.

Keywords: autoimmune; coronavirus; covid 19; covid-19 outbreak; hashimoto; hashimoto’s encephalopathy; thyroid; thyroiditis; viral disease.
 
Back
Top Bottom